Therapy with coenzyme Q.sub.10 of patients having AIDS or other retroviral diseases
US5011858A · kind A · utility
1Cited by
3References
16Claims
0Family size
Assignee
Inventors
Key dates
| Filing date | Sep 21, 1987 |
| Grant date | Apr 30, 1991 |
| Priority date | — |
| Expiry date | Sep 21, 2007 |
Classification
- Technology area (CPC A)Human Necessities
- CPC primaryA61K31/12
- WIPO fieldPharmaceuticals
- WIPO sectorChemistry
Abstract
Therapy with a pharmaceutical formulation of coenzyme Q.sub.10 (CoQ.sub.10) of patients with Acquired Immune Deficiency Syndrome, known by the acronym AIDS and of patients with other retroviral diseases including the AIDS-related complex known as ARC is useful to reduce or negate opportunistic infections, adenopathy and other undesirable clinical symptoms. CoQ.sub.10 therapy may be used in conjunction with antibiotic therapy to prevent or suppress secondary opportunistic infections.
Source: USPTO / EPO open patent data. Objective bibliographic and citation counts.